Fig. 19. Schematic illustration of the proposed nanocarrier based on MSNs loaded with osteostatin and siRNA to knockdown SOST. Both in vitro and in vivo results showed an increased in the gene expression of early osteogenic differentiation markers.631 Reproduced with permission from ref. 631. Copyright 2019, American Chemical Society.
